Antimicrobial & Chemotherapy
🟢 Lite — Quick Review (1h–1d)
Rapid summary for last-minute revision before your exam.
Antimicrobial chemotherapy is the selective use of chemical agents to kill or inhibit infecting microbes (bacteria, mycobacteria, fungi, viruses, protozoa) while sparing the host — the principle of selective toxicity. Agents are classified by spectrum (narrow vs broad), activity (bacteriostatic vs bactericidal), and PK/PD drivers (time-dependent vs concentration-dependent killing).
- Five mechanisms: cell-wall inhibition, protein synthesis (50S/30S), nucleic acid synthesis, antimetabolite action, membrane disruption.
- Bactericidal drugs are mandatory in endocarditis, meningitis, and neutropenic sepsis.
- PD targets: β-lactams need T>MIC ≥ 40–50%; aminoglycosides need Peak/MIC ≥ 8–10 and AUC/MIC ≥ 400; fluoroquinolones need AUC/MIC ≥ 25.
| Category | Best PK/PD index | Dosing implication |
|---|---|---|
| β-lactams, vancomycin | T > MIC | Frequent dosing or continuous infusion |
| Aminoglycosides, fluoroquinolones, daptomycin | Peak/MIC, AUC/MIC | Once-daily high dose |
🟡 Standard — Regular Study (2d–2mo)
Standard content for students with a few days to months.
Mechanism-based Classification
Every NEET PG question on this topic hinges on matching the drug to one of five molecular targets. Inhibitors of cell-wall synthesis (β-lactams, glycopeptides, fosfomycin, D-cycloserine) bind PBPs or block peptidoglycan cross-linking. Protein synthesis inhibitors bind either the 50S subunit (macrolides, clindamycin, chloramphenicol, linezolid) or the 30S subunit (aminoglycosides, tetracyclines). Nucleic acid inhibitors include fluoroquinolones (DNA-gyrase/topoisomerase IV) and rifampicin (bacterial RNA polymerase). Antimetabolites (sulfonamides, trimethoprim, dapsone, flucytosine) block folic acid pathways. Membrane disruptors (polymyxins, daptomycin, amphotericin B, azoles) breach or bind ergosterol.
Pharmacokinetic–Pharmacodynamic Categories
| PK/PD class | Driver | Optimising index | Drugs |
|---|---|---|---|
| Concentration-dependent + PAE | Cmax, AUC | Peak/MIC ≥ 8–10; AUC/MIC ≥ 400 (AG) or ≥ 25 (FQ) | Aminoglycosides, fluoroquinolones, daptomycin |
| Time-dependent, minimal PAE | Duration above MIC | T > MIC ≥ 40–50% | β-lactams, vancomycin |
| Time-dependent, long PAE | AUC | AUC/MIC | Tetracyclines, macrolides, clindamycin |
- Loading dose = (Cₚ desired × Vd) × F, used for aminoglycosides and vancomycin to reach therapeutic levels fast.
- Renal adjustment uses Cockcroft-Gault: CrCl = [(140 − age) × wt × 0.85 if female] ÷ (72 × SCr).
- Resistance arises via β-lactamases, AMEs, PBP2′ in MRSA, 23S rRNA methylation, porin loss, efflux pumps (Tet), or target bypass.
Indications for Combination Therapy
- Synergism — β-lactam + aminoglycoside in enterococcal endocarditis; TMP-SMX in Pneumocystis.
- Spectrum broadening — empiric therapy in sepsis before cultures.
- Resistance prevention — TB (HRZE), HIV (HAART), malaria (ACT).
🔴 Extended — Deep Study (3mo+)
Comprehensive coverage for students on a longer study timeline.
Worked Numeric — Renal-adjusted Aminoglycoside Dosing
A 65-year-old male, 70 kg, SCr 2.0 mg/dL, needs gentamicin for Pseudomonas pneumonia. Estimate CrCl: CrCl = [(140 − 65) × 70] ÷ (72 × 2.0) = 36.4 mL/min — so the dosing interval extends from 8 h to 24 h, or the dose is reduced by the same factor. A target Peak/MIC of 8–10 for an MIC of 2 mg/L requires Cmax 16–20 mg/L — achievable with a 7 mg/kg loading dose and once-daily extended-interval administration.
Edge Cases & Traps
- Vancomycin is time-dependent, not concentration-dependent; trough monitoring (15–20 mg/L for MRSA pneumonia) is the surrogate for T>MIC.
- Macrolides are bacteriostatic, but azithromycin concentrates inside macrophages, making it effective against intracellular Legionella and Chlamydia.
- Bacteriostatic vs bactericidal matters clinically in endocarditis, meningitis, and neutropenic sepsis — use bactericidal agents there.
- De-escalation from broad-spectrum empiric therapy to the narrowest agent guided by culture data reduces C. difficile and resistance.
- β-lactamase inhibitors (clavulanate, sulbactam, tazobactam) lack intrinsic activity but protect the partner β-lactam — recall they themselves have no useful MIC.
Common Exam Mistakes
| Mistake | Correction |
|---|---|
| Treating vancomycin as concentration-dependent | It is time-dependent (T>MIC) |
| Using broad-spectrum empirically forever | De-escalate to narrowest agent with sensitivity |
| Ignoring renal adjustment for AGs/vancomycin | Always Cockcroft-Gault before dosing |
| Calling daptomycin safe for pneumonia | It is inactivated by pulmonary surfactant |
Practice prompts:
- A neutropenic patient on imipenem develops ESBL Klebsiella — what is the drug of choice and why?
- Calculate T>MIC percentage for ceftriaxone 1 g IV q12h when MIC = 4 mg/L and free drug stays above MIC for 8 h.
Continue your study
- View this topic in your NEET PG roadmap — see where “Antimicrobial & Chemotherapy” fits in your personalised plan
- Build a quick revision plan — 1-day sprint covering highest-weight topics
- NEET PG exam overview — pattern, eligibility, and syllabus
- All Pharmacology notes — browse sibling topics in this subject
Content adapted based on your selected roadmap duration. Switch tiers using the selector above.
Sources & verification
- Official NEET PG syllabus & pattern: https://natboard.edu.in/viewnbeexam?exam=neetpg
- Editorial methodology: research → draft → fact-verify → curate pipeline
- Reviewed by Pushkar Saini · last updated
- Found an error? Email [email protected] with the page URL and a one-line description — corrections typically actioned within 48 hours.